News
Pascal Soriot is CEO of pharmaceutical company AstraZeneca. As chair of the Sustainable Markets Initiative (SMI) Health System Task Force, Soriot brings together business leaders from across the ...
Sanofi’s board reached out to AstraZeneca Plc Chief Executive Officer Pascal Soriot to sound out his interest in replacing Chris Viehbacher as CEO, according to people familiar with the situation.
What happened next surprised nobody at AstraZeneca. Within weeks, the company’s hard-charging CEO, Pascal Soriot, inserted the company into the front of the race to supply a game-changing vaccine.
When Pascal Soriot was offered the chance to run AstraZeneca Plc in 2012, the British drugmaker lagged in developing immuno-therapies, a new frontier for cancer research; it was poised to lose ...
On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution. “What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that ...
Denise Roland. Share. Resize. AstraZeneca CEO Pascal Soriot has said 2017 would be the year sales would bottom out and start to grow strongly. Photo: toby melville/Reuters.
FRANKFURT (Reuters) - Long-serving AstraZeneca boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take over in 2023 ...
PASCAL SORIOT: Well, first of all, we, I think, should recognize there are some positive aspects to the IRA. In particular, the fact that copay cap has been introduced, ...
Hosted on MSN9mon
AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results - MSNThe probe centers around AstraZeneca’s eight or nine employees, Soriot said in a Bloomberg TV interview, noting that the firm employs 12,000 people in the country.
Is any employee worth paying £18.7m? That’s the monster sum AstraZeneca has awarded its chief executive, Pascal Soriot, who’s in line for a £1.5m salary with the rest in mostly share-based ...
Hosted on MSN3mon
Watch CNBC's full interview with AstraZeneca CEO Pascal Soriot on its $2.5 billion China investmentPascal Soriot, CEO of British pharmaceutical giant AstraZeneca, discusses the company's $2.5 billion investment in a new China research and development center. Musk to Receive Top-Secret Briefing ...
AstraZeneca boss Pascal Soriot scooped his biggest-ever pay deal last year – taking his total earnings to £135million during his 12-year tenure. The pharmaceutical giant’s long-standing chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results